Evaluate, a provider of commercial intelligence and predictive analytics, agreed to merge with Managed Markets Insight & Technology, a provider of formulary tools and solutions, in a $1.6bn deal. MMIT’s equity partner, Welsh Carson Anderson & Stowe and Evaluate’s equity partner, Hg, will share joint control of the combined business. "MMIT and Evaluate share a mission of helping patients get access to lifesaving therapies. As customers’ decision-making processes become increasingly more centralized, we couldn’t be more thrilled to come together and offer a comprehensive solution for bringing new drugs to market and to patients," Mike Gallup, MMIT CEO.